Get Cannabidiol CBD Oil CAS 13956-29-1 CBD Isolate Powder for Sale at PurelyChem!
Cannabidiol CBD Oil CAS 13956-29-1 CBD Isolate Powder online is the major non-psychotropic component of Cannabis sativa glandular hairs. It has anticonvulsant, sedative, hypnotic, antipsychotic, and anti-inflammatory activities, and neuroprotective qualities. It is a significant phytocannabinoid that binds to several physiological targets of the endocannabinoid system in the body, accounting for up to 40% of the Cannabis plant’s extract.
CBD has shown potential as a therapeutic and pharmaceutical treatment target, while the specific medicinal consequences are still being explored. CBD has demonstrated analgesic, anticonvulsant, muscle relaxant, anxiolytic, anti-inflammatory, antipsychotic, neuroprotective, and antioxidant properties, among other currently researched uses.
PurelyChem is the best platform for you to buy Cannabidiol CBD Oil CAS 13956-29-1 CBD Isolate Powder online. Place an order today!
Cannabidiol CBD Oil CAS 13956-29-1 CBD Isolate Powder for sale was used in the product Sativex in combination with delta-9-tetrahydrocannabinol for the following indications: as an adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy; as an adjunctive treatment for symptomatic relief of neuropathic pain in adult patients with multiple sclerosis who have not responded adequately to other treatment.
CBD’s neuroprotective effects have been widely documented, owing to its anti-inflammatory and antioxidant qualities. CBD’s neuroprotective function has recently been verified in a mouse model of ischemia, where CBD inhibits myeloperoxidase via a cannabinoid receptor-independent mechanism, in addition to a 5HT1A receptor action. CBD has also been shown to prevent binge ethanol-induced neurotoxicity via an antioxidant mechanism that is independent of cannabinoid receptors. CBD’s ability to reduce the excessive generation of peroxynitrites generated by glutamate also contributes to its neuroprotective benefits, as shown by in vitro findings indicating CBD’s ability to prevent retinal apoptosis.